Report Detail

Pharma & Healthcare Global (United States, European Union and China) Demerol (Meperidine) Market Research Report 2019-2025

  • RnM3653184
  • |
  • 07 August, 2019
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Demerol (meperidine), chemically known as ethyl 1-methyl-4-phenylisonipecotate hydrochloride, is an opioid pain medication. Meperidine is used to treat moderate-to-severe pain.
An opioid is sometimes referred to as narcotics. Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties.
In 2019, the market size of Demerol (Meperidine) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Demerol (Meperidine).

This report studies the global market size of Demerol (Meperidine), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Demerol (Meperidine) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Purdue Pharma
Egalet
Boehringer Ingelheim
Janssen
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals
Actavis
Pfizer

Market Segment by Product Type
Powder
Liquid

Market Segment by Application
Anesthesia
Cough Treatment
Diarrhea Treatment

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Demerol (Meperidine) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Demerol (Meperidine) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Demerol (Meperidine) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Demerol (Meperidine) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Powder
      • 1.3.3 Liquid
    • 1.4 Market Segment by Application
      • 1.4.1 Global Demerol (Meperidine) Market Share by Application (2019-2025)
      • 1.4.2 Anesthesia
      • 1.4.3 Cough Treatment
      • 1.4.4 Diarrhea Treatment
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Demerol (Meperidine) Market Size
      • 2.1.1 Global Demerol (Meperidine) Revenue 2014-2025
      • 2.1.2 Global Demerol (Meperidine) Sales 2014-2025
    • 2.2 Demerol (Meperidine) Growth Rate by Regions
      • 2.2.1 Global Demerol (Meperidine) Sales by Regions 2014-2019
      • 2.2.2 Global Demerol (Meperidine) Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Demerol (Meperidine) Sales by Manufacturers
      • 3.1.1 Demerol (Meperidine) Sales by Manufacturers 2014-2019
      • 3.1.2 Demerol (Meperidine) Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Demerol (Meperidine) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Demerol (Meperidine) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Demerol (Meperidine) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Demerol (Meperidine) Price by Manufacturers
    • 3.4 Key Manufacturers Demerol (Meperidine) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Demerol (Meperidine) Market
    • 3.6 Key Manufacturers Demerol (Meperidine) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Powder Sales and Revenue (2014-2019)
      • 4.1.2 Liquid Sales and Revenue (2014-2019)
    • 4.2 Global Demerol (Meperidine) Sales Market Share by Type
    • 4.3 Global Demerol (Meperidine) Revenue Market Share by Type
    • 4.4 Demerol (Meperidine) Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Demerol (Meperidine) Sales by Application

    6 United States

    • 6.1 United States Demerol (Meperidine) Breakdown Data by Company
    • 6.2 United States Demerol (Meperidine) Breakdown Data by Type
    • 6.3 United States Demerol (Meperidine) Breakdown Data by Application

    7 European Union

    • 7.1 European Union Demerol (Meperidine) Breakdown Data by Company
    • 7.2 European Union Demerol (Meperidine) Breakdown Data by Type
    • 7.3 European Union Demerol (Meperidine) Breakdown Data by Application

    8 China

    • 8.1 China Demerol (Meperidine) Breakdown Data by Company
    • 8.2 China Demerol (Meperidine) Breakdown Data by Type
    • 8.3 China Demerol (Meperidine) Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Demerol (Meperidine) Breakdown Data by Company
    • 9.2 Rest of World Demerol (Meperidine) Breakdown Data by Type
    • 9.3 Rest of World Demerol (Meperidine) Breakdown Data by Application
    • 9.4 Rest of World Demerol (Meperidine) Breakdown Data by Countries
      • 9.4.1 Rest of World Demerol (Meperidine) Sales by Countries
      • 9.4.2 Rest of World Demerol (Meperidine) Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Purdue Pharma
      • 10.1.1 Purdue Pharma Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Demerol (Meperidine)
      • 10.1.4 Demerol (Meperidine) Product Introduction
      • 10.1.5 Purdue Pharma Recent Development
    • 10.2 Egalet
      • 10.2.1 Egalet Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Demerol (Meperidine)
      • 10.2.4 Demerol (Meperidine) Product Introduction
      • 10.2.5 Egalet Recent Development
    • 10.3 Boehringer Ingelheim
      • 10.3.1 Boehringer Ingelheim Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Demerol (Meperidine)
      • 10.3.4 Demerol (Meperidine) Product Introduction
      • 10.3.5 Boehringer Ingelheim Recent Development
    • 10.4 Janssen
      • 10.4.1 Janssen Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Demerol (Meperidine)
      • 10.4.4 Demerol (Meperidine) Product Introduction
      • 10.4.5 Janssen Recent Development
    • 10.5 Sanofi
      • 10.5.1 Sanofi Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Demerol (Meperidine)
      • 10.5.4 Demerol (Meperidine) Product Introduction
      • 10.5.5 Sanofi Recent Development
    • 10.6 Sun Pharmaceuticals
      • 10.6.1 Sun Pharmaceuticals Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Demerol (Meperidine)
      • 10.6.4 Demerol (Meperidine) Product Introduction
      • 10.6.5 Sun Pharmaceuticals Recent Development
    • 10.7 Mallinckrodt Pharmaceuticals
      • 10.7.1 Mallinckrodt Pharmaceuticals Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Demerol (Meperidine)
      • 10.7.4 Demerol (Meperidine) Product Introduction
      • 10.7.5 Mallinckrodt Pharmaceuticals Recent Development
    • 10.8 Endo Pharmaceuticals
      • 10.8.1 Endo Pharmaceuticals Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Demerol (Meperidine)
      • 10.8.4 Demerol (Meperidine) Product Introduction
      • 10.8.5 Endo Pharmaceuticals Recent Development
    • 10.9 Actavis
      • 10.9.1 Actavis Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Demerol (Meperidine)
      • 10.9.4 Demerol (Meperidine) Product Introduction
      • 10.9.5 Actavis Recent Development
    • 10.10 Pfizer
      • 10.10.1 Pfizer Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Demerol (Meperidine)
      • 10.10.4 Demerol (Meperidine) Product Introduction
      • 10.10.5 Pfizer Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Demerol (Meperidine) Sales Channels
      • 11.2.2 Demerol (Meperidine) Distributors
    • 11.3 Demerol (Meperidine) Customers

    12 Market Forecast

    • 12.1 Global Demerol (Meperidine) Sales and Revenue Forecast 2019-2025
    • 12.2 Global Demerol (Meperidine) Sales Forecast by Type
    • 12.3 Global Demerol (Meperidine) Sales Forecast by Application
    • 12.4 Demerol (Meperidine) Forecast by Regions
      • 12.4.1 Global Demerol (Meperidine) Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Demerol (Meperidine) Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Demerol (Meperidine). Industry analysis & Market Report on Demerol (Meperidine) is a syndicated market report, published as Global (United States, European Union and China) Demerol (Meperidine) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Demerol (Meperidine) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,584.64
      3,876.96
      5,169.28
      3,017.60
      4,526.40
      6,035.20
      510,433.60
      765,650.40
      1,020,867.20
      273,486.40
      410,229.60
      546,972.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report